Could the key to detecting Alzheimer’s disease lie in a simple eye examination? According to new research, the answer may be yes. A recent study published in Alzheimer’s & Dementia suggests that one day routine retinal scans could help identify early signs of Alzheimer’s and other dementia, potentially decades before symptoms appear. The results of a team at the Jackson Laboratory (Jax) offer compelling proof that the eye can serve as a window to brain health.
The study focused on a genetic mutation known as the MTHFR677C> T, which is found in up to 40% of people and is associated with increased risk of Alzheimer’s disease. Researchers observed that mice with this mutation showed abnormal changes in the blood vessels in their retina – specifically, twisted and irregular vessels, narrowed arteries and reduced branching. These changes were clear already at the age of six months in the mice, long before cognitive symptoms could be expected.
“If you are at an optometrist or ophthalmology agreement, and they can see odd vascular changes in your retina, it can potentially represent something that also happens in your brain,” said Alaina Reagan, a neuroscientist at Jax, who led the study with Gareth Howell, professor and Diana Davis Spencer Foundation President of Glaucoma Research. This connection between retina and brainwashing health could make eye examinations a powerful tool for early detection of neurodegenerative diseases.
The retina is part of the central nervous system and shares many properties with the brain. Reagan explained that the neurons, the immune cells and other cellular structures in the retina closely mirror them in the brain and they react similarly under disease conditions. “Your retina is essentially your brain, but it is much more accessible because your student is just a hole and we can see lots of things,” she said.
In the study, retinal glands of mice with MTHFR677C> t -mutation emerged vessels that were more twisted and looped than usual, a pattern that may indicate blood flow problems and hypertension. These vascular abnormalities are not only markers of potential eye disease, but also reflect systemic problems that can affect the brain and other organs. This finding increases growing evidence that health health plays a key role in the development of Alzheimer’s and related dementia.
I found this detail striking: the same research team observed previously similar vascular changes in the brain in mice with the same mutation. In their 2022 study, they noticed reduced vensity and blood flow in cortex, the outer layers of the brain, which was responsible for many higher-order functions. The consistency of these findings between the brain and the retina strengthens the case to use eye health as a power of attorney for brain health.
In addition to blood vessels, researchers also change disorders of how retina and brain cells handle energy, clear damaged proteins and maintain structural integrity. These molecular changes suggest that the MTHFR677C> T mutation affects several systems simultaneously, strengthening the idea that the retina and brain are functionally interconnected.
It is important that the study also examined how age and gender affect these vascular changes. Female mice with the mutation showed more serious results, including reduced vessel density and branching by 12 months of age. This repeats wider epidemiological patterns as women are statistically more likely to develop dementia than men, according to the World Health Organization.
To determine if these findings apply to humans, the Jax team collaborates with clinicians and dementia care specialists at Northern Light Acadia Hospital in Bangor, Maine. Their goal is to investigate whether similar retina changes occur in people with MTHFR677C> T mutation and whether these changes can be detected through routine eye examinations. In that case, this could open a new limit in the early Alzheimer’s detection.
“Most people over 50 have a kind of vision reduction and are checked annually for prescription changes,” Reagan noted. “Are they more in danger if they have these vascular changes, and is it a point where doctors could begin to reduce brain changes?” This question emphasizes the potential of eye examinations to serve not only as a diagnostic tool, but also as a preventive measure, identifying individuals who are at risk long before cognitive symptoms emerge.
The consequences of this research are significant. Alzheimer’s and other dementia are complex conditions affected by a combination of genetic and environmental factors. While no single test can capture the full image, the ability to detect early vascular changes in the retina could give a valuable piece of the puzzle. It can also help clinicians to adapt care by identifying patients who can benefit from closer monitoring or early interventions.
As science continues to evolve, the integration of retinal image emissions in routine health screenings can become a practical and non -invasive way of assessing brain health. For the time being, research gives a hopeful glimpse of how progress in eye care can contribute to the fight against neurodegenerative disease.
Read more at Medicalxpress.com